Researcher.Life Logo

Revista Española de Podología : Impact Factor & More

pISSN: 0210-1238
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Revista Española de Podología Journal Specifications

Indexed in the following public directories

  • DOAJ DOAJ
Overview
Language English,Spanish
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish,Spanish
Website URLVisit website
Publication Details
Other chargesVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY
OA statementVisit website
View less

Planning to publish in Revista Española de Podología ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Revista Española de Podología

Preoperative proprotein convertase subtilisin/kexin type 9 inhibitors versus statins and postoperative adverse events in hyperlipidemia: A nationwide, active-comparator cohort study.
  • 1 Jun 2026
  • Atherosclerosis
The m6A demethylase FTO suppresses perivascular adipose tissue browning and exacerbates vascular injury via m6A-mediated destabilization of Irx3 mRNA and the IRX3/UCP1 axis.
  • 14 May 2026
  • Atherosclerosis
Reconsidering the role of liver transplantation in homozygous familial hypercholesterolaemia: beyond last-resort therapy.
  • 13 May 2026
  • Atherosclerosis
Joint associations of the systemic inflammation response index and albumin-globulin ratio with all-cause and cardiovascular mortality across cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study in the UK Biobank.
  • 8 May 2026
  • Atherosclerosis
Organoid models reveal mechanistic connections and sirolimus efficacy in liver-vascular steatosis and foam cell formation.
  • 8 May 2026
  • Atherosclerosis
Urinary orosomucoid and the risk of cardiovascular events and all-cause mortality in the general population. The Tromsø Study 2007-2021.
  • 7 May 2026
  • Atherosclerosis
Preoperative proprotein convertase subtilisin/kexin type 9 inhibitors versus statins and postoperative adverse events in hyperlipidemia: A nationwide, active-comparator cohort study.
  • 1 Jun 2026
  • Atherosclerosis
The m6A demethylase FTO suppresses perivascular adipose tissue browning and exacerbates vascular injury via m6A-mediated destabilization of Irx3 mRNA and the IRX3/UCP1 axis.
  • 14 May 2026
  • Atherosclerosis
Reconsidering the role of liver transplantation in homozygous familial hypercholesterolaemia: beyond last-resort therapy.
  • 13 May 2026
  • Atherosclerosis
Joint associations of the systemic inflammation response index and albumin-globulin ratio with all-cause and cardiovascular mortality across cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study in the UK Biobank.
  • 8 May 2026
  • Atherosclerosis
Organoid models reveal mechanistic connections and sirolimus efficacy in liver-vascular steatosis and foam cell formation.
  • 8 May 2026
  • Atherosclerosis
Urinary orosomucoid and the risk of cardiovascular events and all-cause mortality in the general population. The Tromsø Study 2007-2021.
  • 7 May 2026
  • Atherosclerosis

FAQs on Revista Española de Podología